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Abstract
Background: Acaricides are used to treat and prevent tick infestations, and a common clinical scenario is to
administer an acaricide on observing an attached tick. Consequently, immediate acaricidal efficacy (onset of activity
and speed of kill) results are clinically valuable. This study evaluated the immediate efficacy of four commercially
available acaricides against adult Rhipicephalus sanguineus (sensu lato).
Methods: Forty dogs were blocked on hair length and tick carrying capacity, then randomly assigned to receive
one of four treatments (fluralaner, sarolaner, imidacloprid + permethrin, or afoxolaner) or left untreated as controls.
All dogs were challenged with 50 adult R. sanguineus (s.l.) ticks 48 h prior to treatment. After treatment, in situ tick
thumb counts were conducted at 2, 4, 8, 12 and 24 h; thereafter ticks were removed and counted at 48 h.
Results: Imidacloprid + permethrin had the earliest onset of activity at 2 h (36.9% efficacy) followed at 4 h by
fluralaner (60.2% efficacy) and sarolaner (48.2% efficacy), and lastly afoxolaner at 8 h (90.8% efficacy). Three oral
treatments had an 8 h speed of kill (>90% efficacy) threshold; with corresponding efficacies as: fluralaner (99.6%),
sarolaner (94.7%) and afoxolaner (90.8%). Fluralaner and sarolaner achieved 100% efficacy at 12, 24 and 48 h;
afoxolaner achieved 100% efficacy at 48 h. Imidacloprid + permethrin achieved 80.1% efficacy at 48 h, therefore,
failing to attain the speed of kill 90% efficacy threshold.
Conclusion: The systemically distributed isoxazolines performed much better than cutaneously distributed
imidacloprid + permethrin and are optimal treatment choices against attached ticks based on the combination of
earlier onset of activity and speed of kill. Fluralaner had a 4 h onset of activity, an 8 h speed of kill and achieved
100% efficacy at 12 h.
Keywords: Acaricide, Imidacloprid, Permethrin, Fluralaner, Afoxolaner, Sarolaner, Dog, Tick, Rhipicephalus sanguineus
* Correspondence: robert.armstrong@merck.com
3MSD Animal Health, 2 Giralda Farms, Madison, NJ 07940, USA
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Burgio et al. Parasites & Vectors  (2016) 9:626 
DOI 10.1186/s13071-016-1900-z
Background
Even with the availability of safe and potent acaricides,
the possibility of attached ticks on dogs is always a
concern, perhaps because of weak dog owner adherence
to product administration directions [1–3]. Attached
ticks present a direct threat to dogs from site irritation,
blood loss and anaemia from feeding, as well as present-
ing potentially fatal indirect threats from pathogen
transmission. Therefore, an appropriate response follow-
ing observation of an attached tick on a dog is to care-
fully remove the tick and administer an acaricidal agent
against other attached, but unobserved, ticks. There is
some urgency in tick removal, because there is a ‘win-
dow of opportunity’ following tick attachment before
pathogen transmission occurs and reducing the attach-
ment time could also reduce the risk of pathogen
transmission [4].
This study was designed to measure the immediate effi-
cacy, defined as efficacy against ticks potentially attached
at the time of treatment [5], of four different acaricides.
The immediate acaricidal efficacy profile can include dif-
ferent activity measurements including: onset of activity,
speed of kill and onset of effect. ‘Onset of activity’ is used
to refer to the earliest time that significant parasite killing
activity can be shown after treatment administration [6]
and therefore is the first treatment threshold reached.
Demonstration of a significant difference between treated
and untreated animals is the critical result needed to es-
tablish the onset of activity although significance can be
achieved with comparatively low observed efficacy if a suf-
ficiently large sample size is used. An early ‘onset of activ-
ity’ has value in providing dog owners with rapid evidence
of activity against attached ticks. ‘Speed of kill’ refers to
the time required to achieve a defined efficacy threshold
(usually > 90% for ticks) and can be measured at any
elapsed time point after treatment administration, there-
fore, the elapsed time after treatment should be specified
with the result [7]. Speed of kill has clinical relevance be-
cause it specifies the time to reach the accepted efficacy
threshold. A positive correlation between immediate effi-
cacy and a reduced tick borne pathogen transmission risk
is logical, but is not quantified, and even 100% immediate
efficacy may not completely preclude pathogen transmis-
sion under some circumstances. A third measurement -
often included in approved product labels in Europe - is
the ‘onset of effect’, which refers to the longest time re-
quired to reach the speed of kill efficacy level (90% efficacy
for ticks) during the recommended treatment interval [8].
‘Onset of effect’ is not usually a characteristic of immedi-
ate treatment efficacy because speed of kill is likely to be
slowest toward the end of the treatment interval.
Both systemically and cutaneously distributed acari-
cides are available [8]. Permethrin, a commonly used
synthetic pyrethroid, is applied topically and distributed
cutaneously, and was applied in this study as the com-
bination product imidacloprid + permethrin. Permethrin
is the only component in this combination with acari-
cidal or repellent activity [9]. Fluralaner, afoxolaner and
sarolaner are recently introduced isoxazoline acaricides,
and are administered orally and distributed systemically.
Systemically distributed acaricides can kill attached ticks
at any location on the body when the tick feeds [8, 10];
therefore, systemically distributed isoxazolines may be
expected to have better immediate efficacy, because they
are quickly and widely distributed in the blood circula-
tion. Cutaneously distributed acaricides depend on diffu-
sion to spread over the body surface on the skin,
typically in the lipid layer [8]. Comparative immediate
efficacy results have not previously been reported for
these four commercially available acaricides.
The tick selected for this study was the brown dog tick
Rhipicephalus sanguineus (Latreille, 1806) (sensu lato)
[11] a three-host tick that feeds primarily on dogs and
will occasionally attach to other animals, including
humans [12, 13]. Rhipicephalus sanguineus (s.l.) is prob-
ably the most widely distributed tick species in the world
and is linked to tick-borne pathogen transmission to
both dogs and humans, including Babesia spp., Ehrlichia
spp., and Rickettsia spp. [5, 12–14]. Rhipicephalus san-
guineus ticks are endophilic, i.e. they are often found in-
doors, while most other ixodid ticks tend to complete
their life-cycles outdoors [12, 13] and are negatively geo-
tactic and can be found climbing walls, floors and furni-
ture in infested residences [12, 13]. Rhipicephalus
sanguineus is active all year in warmer climatic zones,
and is an important cause of infestation in the Mediter-
ranean area [12] and apparently has been for millennia
as it was identified on a mummified Egyptian dog [15].
The objective of this study was to evaluate the imme-
diate efficacy of four commercially available acaricides
against adult R. sanguineus (s.l.) to provide valuable in-
formation to veterinarians and dog owners faced with
the situation of treating a dog presented with attached
ticks.
Methods
This was a single centre, parallel group, randomised
block design efficacy study, with the investigator blinded
to treatment status. The study was conducted under the
approval of the Institutional Animal Care and Use Com-
mittee (IACUC) at Clinvet International and IACUC
members had the authority to inspect the study site and
the animals at will. Initially, 48 dogs that had not been
treated with a systemic or topical insecticide within the
previous 12 weeks were selected, confirmed as healthy
based on physical examination and then acclimatized on
site. Forty of the 48 selected dogs were included in the
study based on their tick carrying capacity in a preliminary
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48 h challenge conducted 14 days before treatment ad-
ministration. These 40 dogs were ranked within average
hair length groups (short < 30 mm and medium 30–
50 mm), and then ranked in descending order of pre-
treatment live attached R. sanguineus (s.l.) counts to create
eight blocks of five dogs each. Within blocks, dogs were
randomly allocated to five treatment groups. To achieve
blinding, dogs were randomly assigned to coded treatment
groups by a non-blinded person. Hair length blocking was
used to reduce the chance of introducing an accidental
bias against the cutaneously distributed treatment, which
might be more challenging to apply and therefore have a
slightly slower distribution in a long haired dog. Dogs
were individually housed during the study and received
regular nutrition and water.
For tick challenges, dogs were sedated for approxi-
mately 1 h and placed in an infestation chamber. A bal-
anced sex ratio (50% female: 50% male) of 50 unfed
adult ticks that were at least one week old from a
laboratory-bred strain of R. sanguineus (s.l.) (USA
strain) were used in infestation challenges. Tick chal-
lenges were applied below an imaginary line drawn on
the lateral side of the animal’s body from the shoulder
in a straight line to the greater trochanter of the hip
until the buttocks with the infestation site as close as
possible to the hind leg; however, the ticks could poten-
tially attach to any location on the dog. This approach
was used because attached ticks might be found at
many sites on the dog and therefore it would reduce an
efficacy bias that could occur if ticks were exclusively
applied to the back of the dog close to the administra-
tion site of a cutaneously distributed treatment.
Rhipicephalus sanguineus can attach anywhere but ap-
parently prefer the ears, interdigital spaces, back, in-
guinal region and axillae [13].
The four treatment groups received sarolaner (Simpar-
ica, Zoetis, Florham Park, NJ, USA), afoxolaner (Nex-
Gard, Merial, Lyon, France), fluralaner (Bravecto, MSD
Animal Health, Madison, NJ, USA) or imidacloprid +
permethrin (K9 Advantix, Bayer Animal Health, Lever-
kusen, Germany). All dogs were weighed four days
before treatment and then treatments were administered
to dogs in the appropriate groups according to each
product’s label recommendations. Orally administered
products were placed on the back of the tongue and
then the mouth was checked to ensure the treatment
had been swallowed. The spot-on treatment was applied
at one or four spots along the back according to the
dog’s weight, as specified in the package insert recom-
mendations and dogs were briefly restrained following
treatment to prevent any drip off. Dogs were observed
hourly for at least 4 h after treatment, to monitor for
possible adverse effects and then daily for the balance of
the study period.
In situ (thumb counts) tick counts were conducted at
2, 4, 8, 12 and 24 h after treatment, and a removal tick
count was conducted at 48 h after treatment. Treat-
ments and infestations were co-ordinated at staggered
time points to allow sufficient time to complete all tick
counts. Treatment administration and tick infestation
times for each dog were recorded to ensure that tick
counting and then removal occurred at specified target
times. Ticks were detected in the in situ counts by direct
observation using hair coat parting and palpation for
15 min. The final removal count at 48 h was performed
by using up to 50 combs with a fine tooth comb. Follow-
ing the 48 h removal counts, each dog received a further
combing to ensure that all ticks had been counted and
removed. Removed ticks were classified as either ‘live’ or
‘dead’ and either ‘free’ or ‘attached’ creating four possible
classifications. These classifications were used to calcu-
late the efficacy in two ways, because different efficacy
calculation methods have been proposed for systemic
and cutaneous treatments [5]. Briefly, efficacy calcula-
tions that include live free ticks may not be appropriate
for evaluating systemic treatments that require the tick
to attach in order to be exposed to the active ingredient.
Efficacy against ‘live attached’ ticks = 100 × (Mc – Mt)/
Mc, where:
Mc =Mean number of live attached ticks on animals
in the untreated control group at a specific time point;
Mt =Mean number of live attached ticks on animals
in each treated group at the same specific time point.
Efficacy against ‘live attached and free’
ticks = 100 × (Mc – Mt)/Mc, where:
Mc =Mean number of live free and attached ticks on
animals in the untreated control group at a specific time
point;
Mt =Mean number of live free and attached ticks on
animals in each acaricide treated group at the same spe-
cific time point.
The experimental unit for the statistical analysis is the
individual dog. Groups were compared using an
ANOVA (Proc GLM procedure in SAS Version 9.3 TS
Level 1 M2) with a treatment effect on both untrans-
formed and logarithmic transformed tick (count + 1)
data. The level of significance of the formal tests was set
at 5% and all tests were two sided. The treatment was
considered to have reached the 90% efficacy threshold
only if the untreated control group infestation was also
considered adequate with tick retention greater than
20%, or 10 of the 50 challenge ticks [5]. All treatments
were compared with each other for each of the two dif-
ferent treatment calculation measures.
Results
All dogs completed the study with no reported treat-
ment related adverse effects in any group. Tick
Burgio et al. Parasites & Vectors  (2016) 9:626 Page 3 of 6
infestation adequacy was reached in the control group at
every time point (Table 1). Calculated ‘Live attached’
Tick efficacy results and ‘Live attached and free’ Tick
efficacy results (Fig. 1) are shown for the 48 h period
with results that are significantly lower at each time
point circled in the figure and one-way ANOVA P-
values provided in the legend. ‘Onset of activity’ and
‘speed of kill’ for each treatment group at each tick
count time point were determined from the efficacy re-
sults (Table 2). Total live ticks attached to treated dogs
declined over the 48 h period in all treatment groups
and reached 0 in all treated groups except for the imida-
cloprid + permethrin group (Table 3).
Permethrin had the earliest onset of activity at 2 h
with a comparatively low efficacy level that increased
very slowly over the 48 h study period (Table 2, Fig. 1).
Of the orally administered treatments, fluralaner and
sarolaner had the earliest onset of activity at 4 h. Afoxo-
laner had a comparatively slower 8 h onset of activity.
All of the orally administered treatments achieved the
90% speed of kill threshold by 8 h post-administration
(in order of decreasing efficacy: fluralaner 99.6%; sarola-
ner 94.7%; afoxolaner 90.8%). The potential clinical im-
pact of these efficacy differences is illustrated by
comparing the total live tick counts on all dogs from
each group at 8 h when there were: 113 attached live
ticks counted on the imidacloprid + permethrin group
dogs; 21 live ticks on the afoxolaner group dogs; 12 live
ticks on the sarolaner group dogs; and one live tick on
the fluralaner group dogs (Table 3).
All orally administered products achieved 100% effi-
cacy - using both the ‘live attached ticks’ and ‘live
attached and free ticks’ calculation techniques - during
the study (fluralaner and sarolaner at 12 h and afoxola-
ner at 48 h) (Fig. 1). The topically distributed imidaclo-
prid + permethrin attained a peak efficacy of only 81%
during the 48 h study; therefore, not reaching the 90%
speed of kill threshold (Table 2, Fig. 1). In the imidaclo-
prid + permethrin group there were live ticks attached to
dogs at every time point in the study and 53 ticks
remained attached to dogs in the group at the end of the
48 h study period, while there were no ticks attached to
any dog in the fluralaner and sarolaner groups after 8 h
and in the afoxolaner group at 48 h (Table 3).
Discussion
The objective of this study was to evaluate the immedi-
ate efficacy of four available acaricides that might be
administered in the common clinical scenario where a
veterinarian or owner treats a dog observed to have an
attached tick. These results show that the orally admin-
istered, systemically distributed isoxazolines deliver
significantly better immediate efficacy compared to cuta-
neously distributed permethrin (Table 2, Fig. 1) based on
their speed of kill.
The differences in the mechanism of active ingredient
distribution and the potency of the acaricidal effect for
each active are likely the critical factors explaining
efficacy differences observed between the groups. This
study did not evaluate repellency, because tick infest-
ation challenges were initiated 48 h before treatment
administration and permethrin efficacy typically requires
approximately 7 days after administration to reach peak
levels [8, 16]. Systemic distribution provides a rapid con-
duct of active ingredient to all potential sites of tick
attachment, and is critical for delivering immediate effi-
cacy. In contrast, the immediate efficacy of cutaneously
distributed treatments can be reduced by multiple fac-
tors including: the time required for distribution to body
locations distant to the site of application; lack of uni-
form spread; and, potential for loss from the skin surface
[8]. Prescribing information for permethrin + imidaclo-
prid advises that this combination can take 48 h to kill
ticks attached at the time of treatment [17]; however,
this may be overly optimistic for R. sanguineus (s.l.)
because in this study a total of 53 live ticks remained
attached to dogs in this treatment group at the end of
the 48 h.
The timing of pathogen transmission following attach-
ment of an infected tick is variable, with a general
suggestion that feeding for 24 to 48 h may be needed [4,
18]. Specific impacts of acaricides on tick feeding
Table 1 Live attached R. sanguineus (s.l.) tick counts and infestation adequacy on untreated control group dogs (n = 8) throughout
the 48 h treatment evaluation period that started 48 h after the initial tick challenge




Live attached ticks as % of the 50
challenge ticks per dog
Control group tick infestation level
adequate (>20%)?
2 26.8 ± 6.8 40–67 Yes
4 28.3 ± 4.9 47–66 Yes
8 28.5 ± 4.8 47–67 Yes
12 29.8 ± 5.3 49–70 Yes
24 29.8 ± 5.5 50–71 Yes
48 33.3 ± 6.8 53–80 Yes
Abbreviation: SD standard deviation
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mechanisms and the consequent effects on tick borne
pathogen transmission times were not measured in this
study. Previous research has shown that each treatment
administered in this study can prevent pathogen trans-
mission under specific laboratory conditions [18–20]. If
there is a direct correlation between tick feeding time
and pathogen transmission, then results of this study in-
dicate that there will be differences between the ability
of the acaricides tested to prevent pathogen transmission
from ticks attached at the time of treatment. A treat-
ment that allows more ticks to remain attached for lon-
ger (as seen with the imidacloprid + permethrin group in
this study) will be associated with a potentially greater
risk of transmission of infectious disease pathogens. The
ability of acaricides to prevent pathogen transmission
under specific laboratory conditions [18–21] is not proof
that they eliminate the risk of pathogen transmission
under field conditions because the multiple variables oc-
curring in a natural setting cannot be mimicked in a la-
boratory trial [4, 5]. Furthermore, poor dog owner
compliance with parasite treatment recommendations
[1–3] is another factor that reduces the ability of com-
mercially available acaricides to control the risk of tick
borne parasite transmission. Therefore, an extended per-
sistent duration of acaricidal efficacy against R. sangui-
neus (s.l.) may be as important as immediate efficacy.
Two different efficacy calculations were used in this
study because ‘live attached’ efficacy has been proposed
as a more relevant measure for systemically distributed
treatments while ‘live attached and free’ efficacy may be
a more relevant measure for cutaneously distributed
treatments [5]. The rationale is that systemically distrib-
uted treatments will have no effect on ticks that have
not fed, while cutaneously distributed treatments could
Fig. 1 Efficacy, calculated by two methods, for four acaricidal treatments against attached adult R. sanguineus (s.l.) ticks on dogs over the 48 h
following initial treatment administration. Circled results are significantly lower than all other results for the specific time point. The solid line is
the efficacy calculated using ‘live attached’ ticks and the dashed line is the efficacy calculated using ‘live attached and free’ ticks. One-way ANOVA
results (lowest results compared to next lowest) are consistently afoxolaner vs imidacloprid + permethrin: at 4 h, P = 0.0128 (live attached efficacy);
at 8, 12, 24 and 48 h, P < 0.0001. For ‘live attached and free’ efficacy, one-way ANOVA results at 4 h for afoxolaner vs sarolaner: P = 0.0073
Table 2 Time to onset of activity and speed of kill using two different efficacy calculation methods for acaricidal treatments over















“speed of kill” time
point (%)






and free”) at “speed of
kill” time point (%)
Time to 100% efficacy (the
time was the same for




2 36.9 Not attained Not attained Not attained Not attained Not attained
Fluralaner 4 60.2 8 99.7 8 98.2 12
Sarolaner 4 48.2 8 94.7 12 100 12
Afoxolaner 8 90.8 8 90.8 12 97.9 48
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have an effect on free ticks [5]. However, there was little
difference seen between the results of the two efficacy
calculations in this study (Fig. 1) except for the afoxola-
ner group which showed a distinct dip in efficacy at 4 h
post-treatment using the ‘live attached and free’ efficacy
calculation. Therefore, either calculation method is a
reasonable choice in assessing immediate efficacy.
Conclusions
In conclusion, administration of a systemically distrib-
uted acaricide is a much more effective approach than a
cutaneously distributed acaricide for treating a dog
infested with live attached ticks. Fluralaner had a 4 h
onset of activity, an 8 h speed of kill and achieved 100%
efficacy at 12 h, and is an optimal choice for treating
dogs with attached ticks.
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